The Institute of Medicinal Biotechnology（IMB）of the Chinese Academy of Medical Sciences was founded in 1958 under the original name of the Institute of Antibiotics, where the first penicillin in China was made. Since then, IMB has become the primary institute in China for drugs against infectious diseases as well as other major human diseases. The name of the institute was changed to the Institute of Medicinal Biotechnology in 1986, as the research area was largely extended. “Microbial and Biochemical Pharmaceutics Science” in IMB is the State-Key Academic Subject holding several national drug R&D platforms or key laboratories. Together with the education section (PhD / MS programs) and institute-owned pharmaceutical / biotech firms, IMB represents a comprehensive drug discovery base for research, teaching and technical transformation.